KOPRAN.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 11:59):

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally...

Stats
Dagens volum	461 859
Gjennomsnittsvolum	533 225
Markedsverdi	12.73B
EPS	INR0 ( 2024-02-06 )
Neste inntjeningsdato	( INR0 ) 2024-05-23
Last Dividend	INR3.00 ( 2023-09-07 )
Next Dividend	INR0 ( N/A )
P/E	31.58
ATR14	INR0.360 (0.14%)

Volum Korrelasjon

Lang: 0.16 (neutral)

Kort: -0.52 (weak negative)

Signal:(36.499) Neutral

Kopran Limited Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Kopran Limited Korrelasjon - Valuta/Råvare

-0.28
( neutral )

0.22
( neutral )

0.00
( neutral )

-0.29
( neutral )

-0.20
( neutral )

-0.46
( neutral )

Kopran Limited Økonomi

Annual	2022
Omsetning:	INR5.51B
Bruttogevinst:	INR1.92B (34.92 %)
EPS:	INR5.65

FY	2022
Omsetning:	INR5.51B
Bruttogevinst:	INR1.92B (34.92 %)
EPS:	INR5.65

FY	2022
Omsetning:	INR4.74B
Bruttogevinst:	INR1.90B (40.10 %)
EPS:	INR13.77

FY	2021
Omsetning:	INR4.81B
Bruttogevinst:	INR1.67B (34.72 %)
EPS:	INR14.24

Financial Reports:

No articles found.

Kopran Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Kopran Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.83 - low (27.53%) | Divividend Growth Potential Score: 3.02 - Decrease likely (39.59%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.500	2020-11-05
Last Dividend	INR3.00	2023-09-07
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR9.00	--
Avg. Dividend % Per Year	1.18%	--
Score	2.04	--
Div. Sustainability Score	3.83
Div.Growth Potential Score	3.02
Div. Directional Score	3.43	--

Next Divdend (Est)
(2024-05-20)

INR3.25 Estimate 3.08 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.04

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2020	INR1.500	4.82%
2021	INR1.500	1.08%
2022	INR3.00	0.91%
2023	INR3.00	2.01%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
JKTYRE.NS	Dividend Junior	2023-07-27	Annually	17	0.91%
DIAMONDYD.NS	Dividend Junior	2023-07-27	Annually	7	0.06%
360ONE.NS	Dividend Knight	2023-07-28	Semi-Annually	6	2.85%
SOMANYCERA.NS	Dividend Junior	2023-08-18	Annually	23	0.39%
MOIL.NS	Dividend Knight	2023-09-08	Semi-Annually	14	2.38%
HDFCBANK.NS	Dividend Junior	2023-05-16	Annually	28	0.58%
BHANDARI.NS	Dividend Junior	2023-09-22	Annually	8	0.18%
RAJRATAN.NS	Dividend Junior	2023-07-27	Annually	4	0.12%
KIRLOSIND.NS	Dividend Junior	2023-08-03	Annually	17	0.72%
ENDURANCE.NS	Dividend Junior	2023-08-10	Annually	8	0.30%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0697	1.500	8.61	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0917	1.500	-0.0923	-0.139	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	7.54	1.000	8.32	8.32	[3 - 30]
operatingCashFlowPerShareTTM	8.79	2.00	7.07	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.38	2.00	8.31	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.356	1.000	7.40	7.40	[0.2 - 0.8]
operatingProfitMarginTTM	0.101	1.000	9.97	9.97	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.83

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	30.92	1.000	6.98	0	[1 - 100]
returnOnEquityTTM	0.0917	2.50	-0.0594	-0.139	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.38	2.00	8.87	10.00	[0 - 30]
dividendYielPercentageTTM	1.159	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.79	2.00	7.07	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0955	1.500	-3.97	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0732	1.000	-0.670	0	[0.1 - 0.5]
Total Score				3.02

Kopran Limited

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.